The U.S. Food and Drug Administration recently expanded approval of the nasal spray SPRAVATO, a ketamine-derived drug, as a treatment for depression. A clinic in Denver is looking to help those ...
A new study has found small amounts of liquid ketamine administered in a clinical setting can significantly reduce symptoms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback